# ENTEREG
> **NDA021775** · New Drug Application · Sponsor: CUBIST PHARMS · Approved 2008-05-20
## Drug
- **FDA Application Number:** NDA021775
- **Application type:** New Drug Application
- **Brand name:** ENTEREG
- **Generic name:** Alvimopan
- **Active ingredients:** ALVIMOPAN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CUBIST PHARMS
- **First approval:** 2008-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021775)
---
*AI Analytics · CC0 1.0*